Erythroblastosis Fetal

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2019-10-02
Clinical Trial Update: EPO-4-Rhesus Study [Phase 2, Phase 3]
Phase 2/Phase 3 clinical trial update for an intervention related to fetal erythroblastosis and Rh disease; current status is unknown.